The present invention is concerned with novel sulfonamides of formula ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3 and n are as described in the description and claims. The compounds are orexin receptor antagonists, useful in the treatment of disorders, in which orexin pathways are involved.